Maximilian A. Zierke, Christine Rangger, Kimia Samadikhah, Christoph Kreutz, Andreas M. Schmid and Roland Haubner*,
{"title":"68Ga 标记的基于 TRAP 的糖苷三聚体用于肝脏功能储备成像","authors":"Maximilian A. Zierke, Christine Rangger, Kimia Samadikhah, Christoph Kreutz, Andreas M. Schmid and Roland Haubner*, ","doi":"10.1021/acs.jmedchem.4c0200610.1021/acs.jmedchem.4c02006","DOIUrl":null,"url":null,"abstract":"<p >The exclusive asialoglycoprotein receptor (ASGR) expression on hepatocytes makes it an attractive target for imaging of the functional liver reserve. Here, we present a set of TRAP-based glycoside trimers and evaluate their imaging properties compared to the gold standard [<sup>99m</sup>Tc]Tc-GSA. The click-chemistry-based synthesis approach provided easy access to trimeric low-molecular-weight compounds. Labeling with <sup>68</sup>Ga was carried out in high radiochemical yields (>99%). Complexes showed high stability and hydrophilicity. Protein binding ranged between 10 and 25%. Highest binding affinity (IC<sub>50</sub>) and best liver accumulation were found for [<sup>68</sup>Ga]Ga-<b>T3N3</b>, followed by [<sup>68</sup>Ga]Ga-<b>T3G3</b> and [<sup>68</sup>Ga]Ga-<b>T0G3</b>. Rapid elimination from the rest of the body resulted in excellent target-to-background ratios. Our studies confirmed that high ASGR uptake depends on the correct spacer design and that <i>N</i>-acetylgalactosamine improves targeting properties <i>in vivo</i>. Thus, [<sup>68</sup>Ga]Ga-<b>T3N3</b> represents a new low-molecular-weight radiopharmaceutical with pharmacokinetics similar to those of [<sup>99m</sup>Tc]Tc-GSA.</p>","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"67 21","pages":"19668–19677 19668–19677"},"PeriodicalIF":6.8000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.acs.org/doi/epdf/10.1021/acs.jmedchem.4c02006","citationCount":"0","resultStr":"{\"title\":\"68Ga-Labeled TRAP-Based Glycoside Trimers for Imaging of the Functional Liver Reserve\",\"authors\":\"Maximilian A. Zierke, Christine Rangger, Kimia Samadikhah, Christoph Kreutz, Andreas M. Schmid and Roland Haubner*, \",\"doi\":\"10.1021/acs.jmedchem.4c0200610.1021/acs.jmedchem.4c02006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >The exclusive asialoglycoprotein receptor (ASGR) expression on hepatocytes makes it an attractive target for imaging of the functional liver reserve. Here, we present a set of TRAP-based glycoside trimers and evaluate their imaging properties compared to the gold standard [<sup>99m</sup>Tc]Tc-GSA. The click-chemistry-based synthesis approach provided easy access to trimeric low-molecular-weight compounds. Labeling with <sup>68</sup>Ga was carried out in high radiochemical yields (>99%). Complexes showed high stability and hydrophilicity. Protein binding ranged between 10 and 25%. Highest binding affinity (IC<sub>50</sub>) and best liver accumulation were found for [<sup>68</sup>Ga]Ga-<b>T3N3</b>, followed by [<sup>68</sup>Ga]Ga-<b>T3G3</b> and [<sup>68</sup>Ga]Ga-<b>T0G3</b>. Rapid elimination from the rest of the body resulted in excellent target-to-background ratios. Our studies confirmed that high ASGR uptake depends on the correct spacer design and that <i>N</i>-acetylgalactosamine improves targeting properties <i>in vivo</i>. Thus, [<sup>68</sup>Ga]Ga-<b>T3N3</b> represents a new low-molecular-weight radiopharmaceutical with pharmacokinetics similar to those of [<sup>99m</sup>Tc]Tc-GSA.</p>\",\"PeriodicalId\":46,\"journal\":{\"name\":\"Journal of Medicinal Chemistry\",\"volume\":\"67 21\",\"pages\":\"19668–19677 19668–19677\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2024-10-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://pubs.acs.org/doi/epdf/10.1021/acs.jmedchem.4c02006\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02006\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c02006","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
68Ga-Labeled TRAP-Based Glycoside Trimers for Imaging of the Functional Liver Reserve
The exclusive asialoglycoprotein receptor (ASGR) expression on hepatocytes makes it an attractive target for imaging of the functional liver reserve. Here, we present a set of TRAP-based glycoside trimers and evaluate their imaging properties compared to the gold standard [99mTc]Tc-GSA. The click-chemistry-based synthesis approach provided easy access to trimeric low-molecular-weight compounds. Labeling with 68Ga was carried out in high radiochemical yields (>99%). Complexes showed high stability and hydrophilicity. Protein binding ranged between 10 and 25%. Highest binding affinity (IC50) and best liver accumulation were found for [68Ga]Ga-T3N3, followed by [68Ga]Ga-T3G3 and [68Ga]Ga-T0G3. Rapid elimination from the rest of the body resulted in excellent target-to-background ratios. Our studies confirmed that high ASGR uptake depends on the correct spacer design and that N-acetylgalactosamine improves targeting properties in vivo. Thus, [68Ga]Ga-T3N3 represents a new low-molecular-weight radiopharmaceutical with pharmacokinetics similar to those of [99mTc]Tc-GSA.
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.